Vaxcyte, Inc

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
  • Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • SutroVax, Inc.
See more in Biomedtracker

Latest on Vaxcyte, Inc

Scrip

China’s Biotech Stocks Proved More Resilient Than US’s Amid Market Turmoil

 
• By Andrew McConaghie, Edwin Elmhirst, and Dexter Jie Yan

While President Trump’s efforts to downsize the US Food and Drug Administration and plans to impose tariffs are currently spooking biopharma investors, some companies were able to defy the gloomy sent

Scrip

Peter Marks’ Departure From FDA Rattles Biopharma Industry

 
• By Mandy Jackson

News that US Food and Drug Administration Center for Biologics Evaluation and Research (CBER) director Peter Marks submitted his resignation, effective 5 April, late in the day on 28 March shook the b

In Vivo

Financing Quarterly Statistics, Q4 2024

 
• By Deanna Kamienski and Maureen Riordan

Biopharma financing during the fourth quarter of 2024 totaled $16.8bn from 251 deals. Of those, 60 reached $100m or more. The follow-on public offering (FOPO) and venture financing categories tied for

In Vivo

In Vivo’s Deal Of The Year: Cast Your Vote!

 
• By Jo Shorthouse

In Vivo’s editors, along with experts from the wider Citeline team, have selected our top four picks for the most significant M&A, alliance and financing deals of 2024. Vote now in the polls belo